InvestorsHub Logo

02opida

04/07/24 7:58 AM

#616460 RE: 02opida #616459

BMY - Bristol Myers Squibb Presents New Interim Long-Term Efficacy Data from the EMERGENT-4 Trial Evaluating KarXT in Schizophrenia at the 2024 Annual Congress of the Schizophrenia International Research Society
[2024-04-06 13:15]

mick

04/07/24 12:02 PM

#616468 RE: 02opida #616459

good morning, happy sunday